HIK — Hikma Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Market Cap
£3.94bn
Enterprise Value
£4.93bn
Revenue
$3.16bn

REG - Hikma Pharmaceutical - Director/PDMR Shareholding
24/04/2023 16:30Announcement
REG - Hikma Pharmaceutical - Directorate Change
12/04/2023 07:00Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
03/04/2023 09:30Announcement
REG - Hikma Pharmaceutical - Block listing Interim Review
03/04/2023 09:30Announcement
REG - Hikma Pharmaceutical - Annual Financial Report and Notice of AGM
16/03/2023 10:30Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
02/03/2023 09:45Announcement
REG - Hikma Pharmaceutical - Final Results
23/02/2023 07:00Announcement
REG - Hikma Pharmaceutical - Holding(s) in Company
17/02/2023 10:30Announcement
REG - Hikma Pharmaceutical - Notice of Results
07/02/2023 09:45Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
01/02/2023 10:30Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
18/01/2023 10:30Announcement
REG - Hikma Pharmaceutical - Holding(s) in Company
18/01/2023 09:45Announcement
REG - Hikma Pharmaceutical - Holding(s) in Company
17/01/2023 12:00Announcement
REG - Hikma Pharmaceutical - Additional Listing
10/01/2023 15:45Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
10/01/2023 09:30Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
03/01/2023 09:30Announcement
REG - Hikma Pharmaceutical - Hikma launches sodium oxybate in the US
03/01/2023 07:00Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
01/12/2022 09:30Announcement
REG - Hikma Pharmaceutical - Hikma Injectables Portugal site visit
30/11/2022 07:00Announcement
REG - Hikma Pharmaceutical - Holding(s) in Company
22/11/2022 11:45Announcement